An Open-label, Phase II Study of AZD4635 in Patients with Prostate Cancer

Trial Identifier: D8731C00001
Sponsor: AstraZeneca
NCTID:: NCT04089553
Start Date: August 2019
Primary Completion Date: June 2021
Study Completion Date: April 2023
Condition: Prostate Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version

Trial Locations